Previous studies have associated GTF2E2 with poor prognosis in various cancers; for example, knockdown of GTF2E2 inhibits the growth and progression of lung adenocarcinoma via RPS4X in vitro and in vivo [16]. This evidence concerns the gene GTF2E2 and cancer.